We therefore selected and cloned the 123 different p53 mutants based on the reported p53 mutation sites identified in RA patients and investigated their drug-resistant effect in RA fibroblast-like synoviocytes (RAFLS). Here, TP53 is linked to rheumatoid arthritis.